Comment le bénéfice par action récent de SLP se compare-t-il aux attentes ?
Comment les revenus de Simulations Plus Inc SLP se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Simulations Plus Inc ?
Quel est le score de qualité des bénéfices pour Simulations Plus Inc ?
Quand Simulations Plus Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Simulations Plus Inc ?
Simulations Plus Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$19.57
Prix d'ouverture
$19.55
Plage de la journée
$18.96 - $19.6
Plage de 52 semaines
$12.39 - $37.67
Volume
75.1K
Volume moyen
362.9K
BPA (TTM)
-3.20
Rendement en dividend
0.00%
Capitalisation boursière
$383.2M
Qu’est-ce que SLP ?
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.